|
Patient: 21 year old female |
History: 21 year-old woman with severe post-partum cardiomyopathy
What device has been placed?
Figure 1 Figure 2
The device was placed approximately 1 year and 9 months ago and there is now purulent discharge at the drive-line skin entrance site. What study would you like to perform next?
Figure 3 Figure 4
Findings and their significance?
Next step in management? |
Image Size:[small][as-submitted]
|
Findings: Limited Leukocyte Scintigraphy
RADIOPHARMACEUTICAL: 0.46 mCi In-111 labeled autologous leukocytes i.v.
Focus of increased tracer uptake in the superficial anterior right mid abdomen
Microbiology (drive Line)
Rare gram positive cocci
Follow Up
The patient was subsequently treated with an LVAD drive line exit site revision |
DDx: Leukocyte scintigraphy evaluates the extent of drive-line and device involvement.
Exit site only
Exit site and drive-line
Exit site, drive-line, and device |
Diagnosis: Left Ventricular Assist Device (LVAD) drive line infection, relatively superficial in location at the skin entrance site.
|
References: Pasque et al. "Surgical Management of Novacor Drive-Line Exit Site Infections" Ann Thorac Surg. 2002; 74:1267-1268. |
Comments: No comments posted. |
Additional Details:
Case Number: 245518Owner(s): Andrew Homb and Jerold Wallis, Assoc Prof of RadiologyLast Updated: 02-07-2013 The reader is fully responsible for confirming the accuracy of this content. |